nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo searchdiv qikanlogo popupnotification paper paperNew
2025, 08, v.66 846-850
基于育心软坚辨治非梗阻性肥厚型心肌病
基金项目(Foundation): 中医药传承与创新“百千万”人才工程(岐黄工程)(国中医药人教函[2021]203号); 天津市名中医传承工作室专项(津卫中[2020]732号)
邮箱(Email): tjzhtcm@163.com;
DOI: 10.13288/j.11-2166/r.2025.08.015
摘要:

总结基于育心软坚理念辨治非梗阻性肥厚型心肌病(HCM)的临证经验。认为HCM属于“心积”范畴,脾肾亏虚为发病之本,痰瘀积聚、气阴耗伤为发病之标。脾肾亏虚,化生痰瘀,痰瘀积聚心体;痰瘀结聚日久,耗伤心之气阴,导致心体失养,久之则表现为心之体用俱损。据此提出育心软坚法治疗非梗阻性HCM,强调软坚散结贯穿治疗全程,常用四味软坚方加减;症状明显期以益气养阴、软坚散结为主要治法,方用自拟育心软坚方加减;病情稳定期以益肾健脾、软坚散结为主要治法,方用自拟脾肾同治方加减。

Abstract:

This article summarized clinical experience in differentiating and treating non-obstructive hypertrophic cardiomyopathy(HCM) based on the concept of nourishing the heart and softening the hardness. It is considered that HCM belongs to the category of "heart accumulation", with the fundamental cause being depletion of the spleen and kidney, and phlegm-stasis accumulation, as well as qi-yin exhaustion, serving as the manifestations. Spleen and kidney depletion leads to the transformation of phlegm and stasis, which accumulate in the heart; over time, this phlegm-stasis accumulation consumes heart qi and yin, resulting in the heart being deprived of nourishment, which eventually leads to the damage to both the function and structure of heart. Therefore, the method of nourishing the heart and softening the hardness is proposed for the treatment of non-obstructive HCM. Emphasis is placed on softening hardness and dissipating masses throughout the entire treatment process, often using Modified Siwei Ruanjian Formula (四味软坚方加减). During periods with prominent symptoms, the main treatment is boosting qi and nourish-ing yin to soften hardness and dissipate masses with self-made Yuxin Ruanjian Formula (自拟育心软坚方) in modifica-tions; in stable periods, the main treatment is boosting kidney and fortifying spleen to soften hardness and dissipate masses with self-made Pishen Tongzhi Formula (脾肾同治方) in modifications.

参考文献

[1]TUOHY CV,KAUL S,SONG HK,et al.Hypertrophic cardiomyopathy:the future of treatment[J].Eur J Heart Fail,2020,22(2):228-240.

[2]国家心血管病中心心肌病专科联盟,中国医疗保健国际交流促进会心血管病精准医学分会“中国成人肥厚型心肌病诊断与治疗指南2023”专家组.中国成人肥厚型心肌病诊断与治疗指南2023[J].中国循环杂志,2023,38(1):1-33.

[3]黄雪云,李七一,严士海.肥厚性心肌病中医研究进展[J].四川中医,2014,32(7):187-188.

[4]高帅飞,杨丽,毛竹青,等.李庆海治疗肥厚型心肌病经验[J].中医杂志,2021,62(8):658-661.

[5]李睿智,刘菲菲,吴琼,等.中医药治疗心肌肥厚的研究进展[J].中医药通报,2024,23(8):63-68.

[6]漆仲文,王晓景,仲爱芹,等.基于育心保脉理论调治冠心病危险因素[J].中医杂志,2017,58(14):1192-1195.

[7]刘金凤,徐利亚,陈靖,等.刘如秀教授治疗肥厚型心肌病经验总结[J].世界中西医结合杂志,2014,9(3):229-231.

[8]李瑞菡,朱春临,景瑞青,等.黄力教授治疗心尖肥厚型心肌病经验[J].中西医结合心脑血管病杂志,2021,19(4):691-693.

[9]彭江扬,王晓丽,何志凌,等.邹旭治疗肥厚型心肌病经验介绍[J].新中医,2017,49(7):149-150.

[10]王晓景,张军平,李明.阮士怡心脾肾三脏同调治疗冠心病经验[J].中医杂志,2017,58(6):464-466.

[11]谢盈彧,方子寒,李渊芳,等.国医大师阮士怡运用育心保脉理论辨治心力衰竭经验[J].中国中西医结合杂志,2020,40(11):1388-1391.

[12]张立双,张俊华,张伯礼,等.浅谈软坚散结法的内涵与外延[J].天津中医药大学学报,2021,40(2):137-141,130.

[13]张军平.国医大师阮士怡集[M].北京:华夏出版社,2023:39-41.

[14]刘宏扬,张睿,任公平.夏枯草提取物对AHF模型大鼠心肌保护作用及SDF-1表达水平的影响[J].中国实验方剂学杂志,2016,22(8):171-176.

[15]孙小慧.浙贝母提取物对异丙肾上腺素诱导H9c2心肌细胞肥厚的干预作用及机制研究[D].杭州:浙江工业大学,2017.

[16]PELLICCIA F,CECCHI F,OLIVOTTO I,et al.Microvascular dysfunction in hypertrophic cardiomyopathy[J].J Clin Med,2022,11(21):6560.

[17]马沛然,黄磊,姜宏磊,等.玉丹荣心丸对改善小鼠病毒性心肌炎心肌病理改变的实验研究[J].山东医药,2004,44(22):22-23.

[18]翟取,孙明杰,崔海峰,等.生脉散对糖尿病大鼠心脏收缩功能的保护作用[J].中华中医药杂志,2020,35(6):2818-2823.

[19]倪青,王阶,赵安斌,等.生脉散对2型糖尿病性心肌病大鼠心肌的保护作用[J].中国中医基础医学杂志,2010,16(7):572-576.

基本信息:

DOI:10.13288/j.11-2166/r.2025.08.015

中图分类号:R259

引用信息:

[1]耿小飞,范新彪,孙夕童等.基于育心软坚辨治非梗阻性肥厚型心肌病[J].中医杂志,2025,66(08):846-850.DOI:10.13288/j.11-2166/r.2025.08.015.

基金信息:

中医药传承与创新“百千万”人才工程(岐黄工程)(国中医药人教函[2021]203号); 天津市名中医传承工作室专项(津卫中[2020]732号)

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文